HepaSphere/Quadrasphere microspheres delivering doxorubicin

doxorubicin · Merit Medical Systems, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HepaSphere/Quadrasphere microspheres delivering doxorubicin, covering 2021-11-30 to 2021-11-30. Get the full timeline:

Most recent: Clinical Trial Update: HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer [Phase 3]

See pricing